NDC 72934-1595-2

This exact product or package identity exists in FDA auxiliary data but is not present in the current primary NDC product table. The package identity is preserved; status rows are reported source observations, not medical conclusions.

Requested NDC: 72934-1595-2
Product root: 72934-1595
Identity scope: Package
Primary current NDC product row: Not present

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
compounder	package	72934-1595	72934-1595-2	COMPOUNDER	Outsourcing facility compounded drug report	2025-2	2026-08-12
compounder	package	72934-1595	72934-1595-2	COMPOUNDER	Outsourcing facility compounded drug report	2025-1	2026-08-12

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 1 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Archive	Snapshot	Source SHA-256
2025-08-27 00:00 UTC · source 2025-08-20	compounder	package	72934-1595	72934-1595-2	COMPOUNDER	Outsourcing facility compounded drug report	2025-1	compounder / compounders_ndc_directory.zip	`af8e9b524e63…`	`ca326a94a5e9…`

Compounder NDC reports#

Browse the complete compounder directory for this NDC · Browse every current compounder row in the unified auxiliary catalog · browse compounder source captures and parsed snapshots.

Establishment, FEI, Product NDC table
Establishment	FEI	Product NDC	Package NDC	Product	Active ingredients	Reporting period	Normalization
SKNV	080105003	72934-1595	72934-1595-2	Niacinamide; Levocetirizine Dihydrochloride; Imiquimod	2 g/100 g; 1 g/100 g; 5 g/100 g	2025-2	valid
SKNV	080105003	72934-1595	72934-1595-2	Niacinamide; Levocetirizine Dihydrochloride; Imiquimod	2 g/100 g; 1 g/100 g; 5 g/100 g	2025-1	valid
GEL		72934-1595		021023 IMIQUIMOD 5% / LEVOCETIRIZINE DIHYDROCHLORIDE 1% / NIACINAMIDE 2%	OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)		source_anomaly